Results 4,361-4,380 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: No, I think Dr. Darina O'Flanagan went a bit further than that.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: What was the title of that conference?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Who organised it?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: GSK? Hopefully not.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Are we looking for experts to give us an out or are we looking to do what the then Minister said, that is, focus on the people affected and their families?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: If our angle here is that Hayes has told us we can win this case, is that our focus or is it to look after the families?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I am not doubting that. If Mr. Breen is my solicitor, I expect him to win for me-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: -----but we are the State and we are also interested in our citizens. Perhaps the definition of Mr. Breen's remit does not sufficiently have to embrace the kind of compassion that we, as public representatives, have to embrace.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: What is the problem with the likes of Hayes ringing the solicitors on the other side to suggest a sit-down and an exchange of views to identify a pathway that keeps everybody happy? My main concern is reducing the effects on the children, who are clearly suffering, but why are we throwing good money after bad? I refer to the €2 million on discovery-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: -----or on obstructing discovery, if one had a particular point of view?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I am not saying Mr. Breen is doing that. He is only as good as the people feeding him the information in the Department of Health, the HSE or wherever.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: They do it every day with the simple phrase "without prejudice". When the agency settles cases, it is often without admission of liability in any event. What is the problem in doing what the Minister said at the time, namely, put the children and the families first?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: How much do we need?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: We accepted the fact that there was so much risk at the beginning, we indemnified the country. We accepted the fact that there was so much risk, we indemnified the GPs, the nurses or whoever was administering it. We got one of our top medical surveillance people to do a report who found what we thought might be found, namely, a 13-fold higher risk in those vaccinated. Why are we still...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: These children will be adults, but they will have missed their education by the time there is any recourse for them. Whoever is on the Committee of Public Accounts in 30 years will be saying, like the case of those affected by thalidomide, that it went through the process, they found a gap, they got out and those 80 children missed out on their lives. All I am asking is that we be a little...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: There are Department of Health people present, and while I appreciate that they might not be directly involved in this case, I hope they could take it back because we are not talking about somebody who ran their car into the back of another who is looking for €2,000 or €3,000. It is about whether somebody will have the mental age of a 15 year old when they reach 25 because they...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I am sorry. I am quoting the then director of the health protection surveillance centre, Dr. Darina O'Flanagan, who stated there was a 13-fold higher risk of narcolepsy in the vaccinated compared with the unvaccinated. We all know pharmaceutical companies around the world have a great deal of money. I have a British Medical Journal article in front of me on the futility of pharma vigilance...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Why did discovery not take as long in the cervical cancer cases?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I put the details on the record at the beginning. We issued patient information leaflets and told people that this vaccine was as safe as the flu vaccine and that it was clinically tested, but it was not. As Mr. Breen said, it might not be as simple as I am putting it, but equally, it is not as grave as he is putting it back to me in response. We are talking about a finite number of...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Our interest is money. I am only applying common sense. I see the potential for liability. Mr. Breen says it is timelines only and that it is not medical. Our own medical physician says there was a 13-fold increase in cases. Mr. Breen went to a conference and he reckons he got good enough angles to mount a defence to state there is no proven link and, therefore, the agency is not obliged...